Aareet Krsna Ganesh Shermon

Title: Aareet Krsna Ganesh Shermon: Innovator in Drug Delivery Technology

Introduction

Aareet Krsna Ganesh Shermon is an innovative inventor based in Waterloo, Canada. He has made significant contributions to the field of drug delivery systems, particularly through his work on aptamer bioconjugate devices. His research focuses on creating effective delivery mechanisms for active agents, especially in the treatment of cancer.

Latest Patents

Aareet holds a patent for an "Aptamer Bioconjugate Drug Delivery Device." This device utilizes nanoparticles made from biopolymers, such as starch, to deliver active agents. The design allows for targeted treatment of specific disorders, with the aptamer serving as a targeting mechanism. The nanoparticles are engineered to be within the size range of 50-150 nm, forming a colloidal dispersion that enhances drug delivery efficiency. The device is designed to ensure sustained release of the drug, facilitating its transportation and uptake into targeted cells.

Career Highlights

Aareet Krsna Ganesh Shermon is currently employed at Ecosynthetix Inc., where he continues to develop innovative solutions in the field of drug delivery. His work is characterized by a commitment to advancing medical technology and improving patient outcomes through targeted therapies.

Collaborations

Aareet collaborates with Ian J McLennan, leveraging their combined expertise to enhance the development of drug delivery systems. Their partnership aims to push the boundaries of current technologies and explore new avenues for effective treatment options.

Conclusion

Aareet Krsna Ganesh Shermon is a notable inventor whose work in drug delivery technology holds promise for the future of cancer treatment. His innovative approach and dedication to research contribute significantly to advancements in medical science.